Neuronal Aralar/AGC1 deficiency impairs social behavior through dopaminergic and redox dysfunction and is rescued by β-hydroxybutyrate
Postnatal neuronal Aralar deficiency leads to social behavior deficits in mice, which can be rescued by β-hydroxybutyrate treatment.
Where it sits
this study against the rest of the glutathione (gsh) corpusSummary and findings
This study investigated the effects of postnatal neuronal Aralar deletion in mice and the potential therapeutic role of β-hydroxybutyrate (BHB). The researchers found that Neu Aralar-KO mice exhibited hyperactivity and deficits in sociability, indicative of ASD-like behaviors. BHB treatment was shown to restore sociability and normalize metabolic alterations.
Abstract
<h4>Background: </h4> Pathogenic variants in SLC25A12/AGC1 (Aralar) have been linked to autism spectrum disorder (ASD), yet the mechanisms connecting neuronal metabolic dysfunction to altered social behavior remain poorly understood. Aralar is a key component of the malate-aspartate shuttle, supporting neuronal oxidative metabolism and lactate utilization. Here, we investigated the consequences of postnatal neuronal Aralar deletion and the therapeutic potential of β-hydroxybutyrate (BHB). <h4>Methods:</h4> We generated neuron-specific Aralar knockout mice (Neu Aralar-KO) using CamKIIα-Cre, producing efficient recombination in cortex, hippocampus, and striatum. Behavioral, transcriptomic, neurochemical, morphometric, histological, and biochemical analyses were performed in adult mice. The effects of systemic BHB administration were assessed using behavioral, metabolic, oxidative stress, and transcriptomic endpoints. <h4>Results:</h4> Despite a 55-65% reduction of Aralar expression in forebrain regions, Neu Aralar-KO mice displayed normal growth, survival, brain structure, and myelination. Unexpectedly, loss of neuronal Aralar did not impair spatial memory, episodic memory, or reversal learning. In contrast, Neu Aralar-KO mice exhibited hyperactivity and a marked deficit in sociability, revealing an ASD-relevant behavioral phenotype. Morphological analysis showed significant remodeling of striatal dendritic spines without changes in spine density. Transcriptomic profiling identified 433 differentially expressed genes, the vast majority being upregulated, with enrichment of pathways related to neuropeptide signaling, synaptic transmission, membrane excitability, and behavior. Notably, genes involved in dopamine (DA) and glutamate handling, synaptic connectivity, neuromodulatory signaling, and ASD-associated pathways were strongly induced. Neurochemical analyses revealed preserved glutamate and GABA levels but reduced striatal DA content accompanied by an increased DOPAC/DA ratio, indicating enhanced DA degradation. DAergic neurons of the ventral tegmental area (VTA) showed minimal recombination, suggesting that DA dysfunction arises through non-cell-autonomous mechanisms. Consistent with increased DA oxidative catabolism, Neu Aralar-KO striata displayed elevated lipid peroxidation, induction of glutathione-related pathways, upregulation of antioxidant genes, and astrocyte activation. Remarkably, BHB treatment restored sociability, normalized striatal metabolic alterations, reduced oxidative stress, and abolished genotype-dependent neurochemical abnormalities. Transcriptomic analyses further revealed that Aralar deficiency recapitulates a substantial fraction of the fasting/BHB-induced epigenetic transcriptional program. <h4>Conclusions:</h4> Postnatal neuronal Aralar deficiency uncouples social behavior from cognitive performance and drives ASD-like phenotypes through a mechanism linking neuronal metabolic dysfunction, oxidative stress, glial activation, and impaired DAergic homeostasis. The rescue of behavioral, metabolic, and redox abnormalities by BHB identifies restoration of metabolic homeostasis as a major therapeutic mechanism and highlights metabolic interventions as promising strategies for AGC1 deficiency and ASD-associated disorders involving neuronal metabolic dysfunction.
Background
This paper addresses the link between neuronal metabolic dysfunction and altered social behavior, particularly in the context of autism spectrum disorder (ASD). Prior research has established that pathogenic variants in SLC25A12/AGC1 are associated with ASD, but the underlying mechanisms are not well understood. Understanding these mechanisms is crucial for developing potential interventions for ASD-related behavioral deficits.
Methods
The study utilized neuron-specific Aralar knockout mice (Neu Aralar-KO) generated using CamKIIα-Cre. Behavioral, transcriptomic, neurochemical, morphometric, histological, and biochemical analyses were conducted in adult mice. The effects of systemic BHB administration were evaluated through various endpoints related to behavior, metabolism, oxidative stress, and gene expression.
Results
Neu Aralar-KO mice displayed a 55-65% reduction in Aralar expression in forebrain regions but showed normal growth and brain structure. They exhibited hyperactivity and a significant deficit in sociability. Transcriptomic profiling revealed 433 differentially expressed genes, predominantly upregulated, with notable changes in pathways related to dopamine and glutamate handling. Neurochemical analyses indicated reduced striatal DA content and increased lipid peroxidation.
Interpretation
The findings suggest that neuronal Aralar deficiency leads to behavioral changes relevant to ASD through metabolic and oxidative stress mechanisms. While the study identifies significant changes in gene expression and neurochemistry, the clinical relevance of these findings in human populations remains uncertain. The reliance on a mouse model and the lack of human data limit the generalizability of the results.
Key findings
- 55-65% reduction of Aralar expression in forebrain regions.
- Neu Aralar-KO mice exhibited hyperactivity and a marked deficit in sociability.
- Transcriptomic profiling identified 433 differentially expressed genes, with the majority being upregulated.
- Reduced striatal DA content accompanied by an increased DOPAC/DA ratio.
- BHB treatment restored sociability and normalized striatal metabolic alterations.
Limitations
- Mouse model may not fully replicate human conditions.
- BHB effects on human subjects remain untested.
- Small sample size not specified.
- Short duration of follow-up for behavioral assessments.
- Potential confounding factors not fully explored.